No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Termn         Results from ACTG A5001/ALLRT

Jeffrey T. Schouten

首页> 外文期刊>Clinical Infectious Diseases >No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Termn Results from ACTG A5001/ALLRT

【24h】

No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Termn Results from ACTG A5001/ALLRT

机译：与包含阿巴卡韦的初始抗逆转录病毒治疗相关的心肌梗塞没有风险：ACTG A5001 / ALLRT的短期和长期结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. Observational and retrospective clinical trial cohorts have reported conflicting results for the association of abacavir use with risk of myocardial infarction (MI), possibly related to issues that may bias estimation of treatment effects, such as time-varying confounders, informative dropout, and cohort loss due to competing events.

机译：背景。观察性和回顾性临床试验队列研究结果表明，使用阿巴卡韦与心肌梗死（MI）的风险存在相互矛盾的结果，可能与可能影响估计治疗效果的问题有关，例如时变混杂因素，信息不足和队列丢失由于竞争事件。

著录项

来源
《Clinical Infectious Diseases》 |2011年第7期|p.929-940|共12页
作者
Jeffrey T. Schouten;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. [J] . Ribaudo HJ, Benson CA, Zheng Y, Clinical infectious diseases . 2011,第7期

机译：含阿巴卡韦的初始抗逆转录病毒治疗无心肌梗塞风险：ACTG A5001 / ALLRT的短期和长期结果。
2. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. [J] . Bedimo RJ, Westfall AO, Drechsler H, Clinical infectious diseases . 2011,第1期

机译：在高效抗逆转录病毒治疗时代，阿巴卡韦的使用和发生急性心肌梗塞和脑血管事件的风险。
3. Abacavir Use and Risk of Acute Myocardial Infarction and Cerebrovascular Events in the Highly Active Antiretroviral Therapyn Era [J] . Pablo Tebas Clinical Infectious Diseases . 2011,第1期

机译：高活性抗逆转录病毒治疗药物时代的阿巴卡韦使用和急性心肌梗塞和脑血管事件的风险
4. Clinical and biochemical factors associated with acute myocardial infarction: Risk factors for acute myocardial infarction [C] . Sounira Mehri, Mohamed Hammami International Conference on Engineering MIS . 2017

机译：与急性心肌梗死相关的临床和生化因素：急性心肌梗死的危险因素
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Editors Choice: No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT [O] . Heather J. Ribaudo, Constance A. Benson, Yu Zheng, -1

机译：编辑选择：与包含阿巴卡韦的初始抗逆转录病毒治疗相关的心肌梗塞风险：ACTG A5001 / ALLRT的短期和长期结果
7. No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT [O] . Ribaudo, Heather J., Benson, Constance A., Zheng, Yu, 2011

机译：初始抗逆转录病毒治疗含阿巴卡韦无心肌梗塞风险：ACTG A5001 / ALLRT的短期和长期结果

No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Termn Results from ACTG A5001/ALLRT

摘要

著录项

相似文献

相关主题

期刊订阅